BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37345659)

  • 1. H2Bub1 loss is an early contributor to clear cell ovarian cancer progression.
    Ferrari AJ; Rawat P; Rendulich HS; Annapragada AV; Kinose Y; Zhang X; Devins K; Budina A; Scharpf RB; Mitchell MA; Tanyi JL; Morgan MA; Schwartz LE; Soong TR; Velculescu VE; Drapkin R
    JCI Insight; 2023 Jun; 8(12):. PubMed ID: 37345659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer.
    Dickson KA; Cole AJ; Gill AJ; Clarkson A; Gard GB; Chou A; Kennedy CJ; Henderson BR; ; Fereday S; Traficante N; Alsop K; Bowtell DD; deFazio A; Clifton-Bligh R; Marsh DJ
    Hum Mol Genet; 2016 Dec; 25(24):5460-5471. PubMed ID: 27798111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.
    Hooda J; Novak M; Salomon MP; Matsuba C; Ramos RI; MacDuffie E; Song M; Hirsch MS; Lester J; Parkash V; Karlan BY; Oren M; Hoon DS; Drapkin R
    Cancer Res; 2019 Feb; 79(4):760-772. PubMed ID: 30563893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H2B monoubiquitination: roles to play in human malignancy.
    Cole AJ; Clifton-Bligh R; Marsh DJ
    Endocr Relat Cancer; 2015 Feb; 22(1):T19-33. PubMed ID: 24891457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells.
    Schneider D; Chua RL; Molitor N; Hamdan FH; Rettenmeier EM; Prokakis E; Mishra VK; Kari V; Wegwitz F; Johnsen SA; Kosinsky RL
    Clin Epigenetics; 2019 Jul; 11(1):98. PubMed ID: 31266541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.
    Zhang K; Wang J; Tong TR; Wu X; Nelson R; Yuan YC; Reno T; Liu Z; Yun X; Kim JY; Salgia R; Raz DJ
    Int J Cancer; 2017 Aug; 141(4):766-777. PubMed ID: 28481029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARID1A mutations in endometriosis-associated ovarian carcinomas.
    Wiegand KC; Shah SP; Al-Agha OM; Zhao Y; Tse K; Zeng T; Senz J; McConechy MK; Anglesio MS; Kalloger SE; Yang W; Heravi-Moussavi A; Giuliany R; Chow C; Fee J; Zayed A; Prentice L; Melnyk N; Turashvili G; Delaney AD; Madore J; Yip S; McPherson AW; Ha G; Bell L; Fereday S; Tam A; Galletta L; Tonin PN; Provencher D; Miller D; Jones SJ; Moore RA; Morin GB; Oloumi A; Boyd N; Aparicio SA; Shih IeM; Mes-Masson AM; Bowtell DD; Hirst M; Gilks B; Marra MA; Huntsman DG
    N Engl J Med; 2010 Oct; 363(16):1532-43. PubMed ID: 20942669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery.
    Spolverini A; Fuchs G; Bublik DR; Oren M
    Oncogene; 2017 Oct; 36(42):5819-5828. PubMed ID: 28604753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of H2B mono-ubiquitination in the initiation and progression of cancer.
    Zhou S; Cai Y; Liu X; Jin L; Wang X; Ma W; Zhang T
    Bull Cancer; 2021 Apr; 108(4):385-398. PubMed ID: 33685627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometriosis-Associated Ovarian Cancer: Population Characteristics and Prognosis.
    Barreta A; Sarian L; Ferracini AC; Eloy L; Brito ABC; de Angelo Andrade L; Derchain S
    Int J Gynecol Cancer; 2018 Sep; 28(7):1251-1257. PubMed ID: 30142123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNF40 regulates gene expression in an epigenetic context-dependent manner.
    Xie W; Nagarajan S; Baumgart SJ; Kosinsky RL; Najafova Z; Kari V; Hennion M; Indenbirken D; Bonn S; Grundhoff A; Wegwitz F; Mansouri A; Johnsen SA
    Genome Biol; 2017 Feb; 18(1):32. PubMed ID: 28209164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.
    Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
    Mod Pathol; 2012 Apr; 25(4):615-24. PubMed ID: 22157930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone H4 basic patch regulates SAGA-mediated H2B deubiquitination and histone acetylation.
    Meriesh HA; Lerner AM; Chandrasekharan MB; Strahl BD
    J Biol Chem; 2020 May; 295(19):6561-6569. PubMed ID: 32245891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
    Ren F; Wang DB; Li T
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone H2B monoubiquitination regulates heart development via epigenetic control of cilia motility.
    Robson A; Makova SZ; Barish S; Zaidi S; Mehta S; Drozd J; Jin SC; Gelb BD; Seidman CE; Chung WK; Lifton RP; Khokha MK; Brueckner M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14049-14054. PubMed ID: 31235600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H2B monoubiquitylation is a 5'-enriched active transcription mark and correlates with exon-intron structure in human cells.
    Jung I; Kim SK; Kim M; Han YM; Kim YS; Kim D; Lee D
    Genome Res; 2012 Jun; 22(6):1026-35. PubMed ID: 22421545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoubiquitination of Histone H2B Blocks Eviction of Histone Variant H2A.Z from Inducible Enhancers.
    Segala G; Bennesch MA; Pandey DP; Hulo N; Picard D
    Mol Cell; 2016 Oct; 64(2):334-346. PubMed ID: 27692985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma.
    Ayhan A; Mao TL; Seckin T; Wu CH; Guan B; Ogawa H; Futagami M; Mizukami H; Yokoyama Y; Kurman RJ; Shih IeM
    Int J Gynecol Cancer; 2012 Oct; 22(8):1310-5. PubMed ID: 22976498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma.
    Katagiri A; Nakayama K; Rahman MT; Rahman M; Katagiri H; Nakayama N; Ishikawa M; Ishibashi T; Iida K; Kobayashi H; Otsuki Y; Nakayama S; Miyazaki K
    Mod Pathol; 2012 Feb; 25(2):282-8. PubMed ID: 22101352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers.
    Xia Z; Cochrane DR; Anglesio MS; Wang YK; Nazeran T; Tessier-Cloutier B; McConechy MK; Senz J; Lum A; Bashashati A; Shah SP; Huntsman DG
    Gynecol Oncol; 2017 Dec; 147(3):642-647. PubMed ID: 29032825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.